Top-News

CAC 40 Index

Index
WKN:  969400 ISIN:  FR0003500008
8.096,22
-0,53%
-42,9894
16:44:22 Uhr
Depot/Watchlist
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,56: VH3D7E
Werbung

Ad-hocs

26.03.25 - GlobeNewswire
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to ...
25.03.25 - GlobeNewswire
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
24.03.25 - GlobeNewswire
Annual General Meeting to be held on Tuesday 29 April 2025 and 2024 Universal Registration Document
L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 ...
24.03.25 - GlobeNewswire
Press Release: Availability of the Q1 2025 Aide mémoire
Availability of the Q1 2025 Aide mémoire Paris, France – March 24, 2025 . Sanofi announced today that its Q1 2025 Aide mémoire is available on the "Investors" page of the ...
21.03.25 - GlobeNewswire
Unibail-Rodamco-Westfield: Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on April 29, 2025
Paris, March 21, 2025 Press release Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-​Rodamco-Westfield ...
20.03.25 - GlobeNewswire
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to ...
10.03.25 - GlobeNewswire
ArcelorMittal announces the publication of its 2024 annual report
10 March 2025, 23.55 CET
10.03.25 - GlobeNewswire
ArcelorMittal publishes its Annual Report 2024 on Form 20-F
ArcelorMittal has filed its Annual Report 2024 on Form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is now available at ...
08.03.25 - GlobeNewswire
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-​breaking positive pivotal data in bullous pemphigoid presented at AAD
05.03.25 - GlobeNewswire
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
Sanofi successfully prices EUR 1.5 billion of bond issue
03.03.25 - GlobeNewswire
ArcelorMittal appoints Everton Negresiolo as CEO of South American Long Products and mining business
Jorge Luiz Ribeiro de Oliveira nominated Executive Vice President of ArcelorMittal
25.02.25 - GlobeNewswire
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma  Approval offers access to new treatment options for newly diagnosed MM patients Approval based ...
22.02.25 - GlobeNewswire
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
ECCO 2025: new duvakitug data reinforce best-​in-class potential in ulcerative colitis and Crohn’s disease
20.02.25 - EQS
EQS-Adhoc: Airbus reports Full-Year (FY) 2024 results
EQS-​Ad-hoc: Airbus SE / Key word(s): Annual Results Airbus reports Full-Year (FY) 2024 results 20-Feb-2025 / 06:30 CET/CEST Disclosure of an inside information acc. to Article 17 ...
19.02.25 - GlobeNewswire
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Sanofi and CD&R sign Opella share purchase agreement
18.02.25 - GlobeNewswire
Full-year 2024 results
Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 victoire.grux@capgemini.com Investor relations: Vincent Biraud Tel.: +33 1 47 54 50 87 vincent.biraud@capgemini.com Full-...
18.02.25 - GlobeNewswire
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the ...
17.02.25 - GlobeNewswire
Change in the composition of Capgemini’s Board of Directors proposed to the 2025 Shareholders’ Meeting
Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 victoire.grux@capgemini.com Investor relations: Vincent Biraud Tel.: +33 1 47 54 50 87 vincent.biraud@capgemini.com ...
13.02.25 - GlobeNewswire
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the ...
13.02.25 - GlobeNewswire
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t ...

Newssuche

Videos

newspaper
16:00 Uhr -2,02%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »